ArticleAnnals of hematology2024

The DHODH inhibitor teriflunomide impedes cell proliferation and enhances chemosensitivity to daunorubicin (DNR) in T-cell acute lymphoblastic leukemia.

Li Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.